![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. (3,4-dimethoxyphenethylaminomethyl)-4-hydroxybenzyl Alcohol
2. 1-(p-hydroxyphenyl)-2-((3,4-dimethoxyphenethyl)amino)ethanol
3. Ta 064
4. Ta-064
1. 71771-90-9
2. R(-)-denopamine
3. Kalgut
4. Ta 064
5. Ta-064
6. 4-[(1r)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol
7. V5f60upd8p
8. Chembl493682
9. Denopamina
10. Denopaminum
11. 4-[(1r)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxy-ethyl]phenol
12. Benzenemethanol, A-[[[2-(3,4-dimethoxyphenyl)ethyl]amino]methyl]-4-hydroxy-,(ar)-
13. Denopaminum [latin]
14. Kalgut (tn)
15. Denopamina [spanish]
16. Denopamine [inn:jan]
17. Unii-v5f60upd8p
18. R()-denopamine
19. Ncgc00094384-01
20. Denopamine [mi]
21. Denopamine (jan/inn)
22. Denopamine [inn]
23. Denopamine [jan]
24. Lopac-d-7815
25. Denopamine [mart.]
26. Denopamine [who-dd]
27. Dsstox_cid_25800
28. Dsstox_rid_81138
29. Dsstox_gsid_45800
30. Gtpl534
31. Schembl218640
32. Dtxsid8045800
33. Chebi:135359
34. Bcp17423
35. Zinc1552175
36. Tox21_111272
37. Bdbm50252956
38. (-)-(r)-1-(p-hydroxyphenyl)-2-((3,4-dimethoxyphenethyl)amino)ethanol
39. Benzenemethanol, Alpha-(((2-(3,4-dimethoxyphenyl)ethyl)amino)methyl)-4-hydroxy-, (r)-
40. Ncgc00015367-01
41. Cas-71771-90-9
42. Hy-119515
43. Cs-0068617
44. R(-)-denopamine, >=98% (hplc), Powder
45. D02614
46. Dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol
47. (r)-4-(2-(3,4-dimethoxyphenethylamino)-1-hydroxyethyl)phenol
48. 4-[(1r)-2-[2-(3,4-
49. 4-[(1r)-2-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-1-hydroxyethyl]phenol
50. (-)-(r)-.alpha.-(((3,4-dimethoxyphenethyl)amino)methyl)-p-hydroxybenzyl Alcohol
51. (-)-(r)-alpha-(((3,4-dimethoxyphenethyl)amino)methyl)-p-hydroxybenzyl Alcohol
Molecular Weight | 317.4 g/mol |
---|---|
Molecular Formula | C18H23NO4 |
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 8 |
Exact Mass | 317.16270821 g/mol |
Monoisotopic Mass | 317.16270821 g/mol |
Topological Polar Surface Area | 71 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 320 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
Adrenergic beta-Agonists
Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)